Antimalarial drug resistance and the importance of drug quality monitoring

Journal of Postgraduate Medicine

Volumn 52, Issue 4, 2006, Pages 288-290

  Green, M D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antimalarials; Counterfeit drugs; Resistance; Substandard drugs

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ;

CONFERENCE PAPER; DISEASE SURVEILLANCE; DRUG MONITORING; DRUG QUALITY; DRUG SURVEILLANCE PROGRAM; QUALITATIVE ANALYSIS; QUALITY CONTROL;

ANTIMALARIALS; DRUG MONITORING; DRUG RESISTANCE; HUMANS; MALARIA; QUALITY CONTROL;

EID: 33845245635     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. World Health Organization Fact Sheet 94. Revised 1998 Oct. Available from: http://www.who.int/mediacentre/factsheets/fs094/en/ (accessed Jan 2006).
2. Rozendaal KJ. Sizing up research. Lancet 2001;357:890.
3. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. Fake artesunate in southeast Asia. Lancet 2001;357:1948-50.
4. Newton PN, Dondorp A, Green M, Mayxay M, White NJ. Counterfeit artesunate antimalarials in southeast Asia. Lancet 2003;362:169.
5. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 2004;9:1241-6.
6. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, et al. Manslaughter by fake artesunate in Asia - Will Africa be next? PLoS Med 2006;3:e197.
7. Newton PN, Green MD, Fernandez FM, Day NP, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis 2006;6:602-13.
8. World Health Organization. http://www.who.int/medicines/services/ counterfeit/faqs /03/en/index.html (accessed Apr. 2006).
9. World Health Organization Fact Sheet 275. Revised 2006 Feb. Available from: http://www.who.int/mediacentre/factsheets/fs275/en/ (accessed Apr. 2006).
10. Basco LK. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg 2004;70:245-50.
11. Risha PG, Shewiyo D, Msami A, Musuki G, Vergote G, Vervaet C, et al. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop Med Int Health 2002;7:701-7.
12. WHO Expert Committee on Specifications for Pharmaceutical Preparations. WHO Technical Report Series 885. WHO: Geneva; 1999.
13. Jähnke RW, Pachaly P, Gobina NP, et al. Concise quality control guide on essential drugs, Vol. II. Thin layer chromatography, German Pharma Health Fund, Frankfurt (1998); Supplement 1999, 2002, 2003 and 2004.
14. Kenyon AS, Flinn PE, Layloff TP. Rapid screening of pharmaceuticals by thin layer chromatography: Analysis of essential drugs by visual methods. J AOAC Int 1995;78:41-9.
15. WHO. Rapid examination methods for counterfeit and substandard drugs: Supplement data for thin layer chromatography. WHO/WPRO/JICWELS. Manila: WHO; 2001.
16. Jähnke RW, Kallmayer HJ, Breyer C, et al. Concise quality control guide on essential drugs, Vol. 1, Colour reactions, German Pharma Health Fund, Frankfurt (1998); Supplements 1999 and 2002.
17. Green MD, Nettey H, Rojas OV, Pamanivong C, Khounsaknalath L, Ortiz MG, et al. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. J Pharm Biomed Anal 2006;[Epub ahead of print].
18. Dhillon A. Bogus drug-makers warrant death penalty. Indian minister says. South China Morning Post 2003;11.
19. Chatterjee P. India's trade in fake drugs - Bringing the counterfeiters to book. Lancet 2001;357:1776.